HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alexander, J. J. Articles by Quigg, R. J. Search for Related Content PubMed PubMed Citation Articles by Alexander, J. J. Articles by Quigg, R. J.

Complement-Dependent Apoptosis and Inflammatory Gene Changes in Murine Lupus Cerebritis¹

Jessy J. Alexander^2,*, Alexander Jacob^*, Lihua Bao^*, R. Loch Macdonald and Richard J. Quigg^*

^* Section of Nephrology, Department of Medicine, and Section of Neurosurgery, Department of Surgery, University of Chicago, Chicago, IL 60637

The role of complement activation in the brains of MRL/lpr lupus mice was determined using the potent C3 convertase inhibitor, CR1-related y (Crry), administered both as an overexpressing Crry transgene and as Crry-Ig. Prominent deposition of complement proteins C3 and C9 in brains of MRL/lpr mice was indicative of complement activation and was significantly reduced by Crry. Apoptosis was determined in brain using different independent measures of apoptosis, including TUNEL staining, DNA laddering, and caspase-3 activity, all of which were markedly increased in lupus mice and could be blocked by inhibiting complement with Crry. Complement activation releases inflammatory mediators that can induce apoptosis. The mRNA for potentially proinflammatory proteins such as TNFR1, inducible NO synthase, and ICAM-1 were up-regulated in brains of lupus mice. Crry prevented the increased expression of these inflammatory molecules, indicating that the changes were complement dependent. Furthermore, microarray analysis revealed complement-dependent up-regulation of glutamate receptor (AMPA-GluR) expression in lupus brains, which was also validated for AMPA-GluR1 mRNA and protein. Our results clearly demonstrate that apoptosis is a prominent feature in lupus brains. Complement activation products either directly and/or indirectly through TNFR1, ICAM-1, inducible NO synthase, and AMPA-GluR, all of which were altered in MRL/lpr mouse brains, have the potential to induce such apoptosis. These findings present the exciting possibility that complement inhibition is a therapeutic option for lupus cerebritis.

This article has been cited by other articles:

				X. Wu, D. Spitzer, D. Mao, S. L. Peng, H. Molina, and J. P. Atkinson Membrane Protein Crry Maintains Homeostasis of the Complement System J. Immunol., August 15, 2008; 181(4): 2732 - 2740. [Abstract] [Full Text] [PDF]

				L. Bao, Y. Wang, A. Chang, A. W. Minto, J. Zhou, H. Kang, M. Haas, and R. J. Quigg Unrestricted C3 Activation Occurs in Crry-Deficient Kidneys and Rapidly Leads to Chronic Renal Failure J. Am. Soc. Nephrol., March 1, 2007; 18(3): 811 - 822. [Abstract] [Full Text] [PDF]